Literature DB >> 14732373

Acute myelopathy. Retrospective clinical, laboratory, MRI and outcome analysis of 49 cases.

Dennis A Nowak1, Sebastian Mutzenbach, Hans H Fuchs.   

Abstract

Forty nine consecutive cases of acute myelopathy were related to the following pathologies: 31 MS, four spinal cord infarction, four parainfectious, one antiphospolipid syndrome and nine of unknown origin. Sensory deficits were most frequent in MS and in myelopathy of unknown origin. In spinal cord infarction motor deficits and sphincter dysfunction were present in all cases. In parainfectious myelopathy sensory-motor deficits and sphincter dysfunction were most frequent. Myelopathy extended over less than two vertebral segments in MS and in myelopathy of unknown origin. Myelopathy extended over more than two vertebral segments in spinal cord infarction and in parainfectious myelopathy. The clinical outcome was good in MS, parainfectious myelopathy and myelopathy of unknown origin, but poor in spinal cord infarction. Our findings suggest that various aetiologies of acute myelopathy may be differentiated on the basis of distinct clinical, MRI, laboratory and outcome data.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14732373     DOI: 10.1016/s0967-5868(03)00065-1

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  3 in total

1.  Acute myelopathy associated with H1N1 virus infection.

Authors:  Dennis A Nowak; Gabriela Griebl; Andreas Bock
Journal:  J Neurol       Date:  2010-07-22       Impact factor: 4.849

2.  Acute spinal-cord ischemia: evolution of MRI findings.

Authors:  Cornelis L Alblas; Willem H Bouvy; Geert J Lycklama À Nijeholt; Jelis Boiten
Journal:  J Clin Neurol       Date:  2012-09-27       Impact factor: 3.077

3.  A comparison between spinal cord infarction and neuromyelitis optica spectrum disorders: Clinical and MRI studies.

Authors:  Jung Lung Hsu; Mei-Yun Cheng; Ming-Feng Liao; Hui-Ching Hsu; Yi-Ching Weng; Kuo-Hsuan Chang; Hong-Shiu Chang; Hung-Chou Kuo; Chin-Chang Huang; Rong-Kuo Lyu; Kun-Ju Lin; Long-Sun Ro
Journal:  Sci Rep       Date:  2019-05-15       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.